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 ABSTRACT 
Ascorbic acid is involved in the formation of nitrogen oxide in 
leukocytes of humans and animals. It is an important role of the AA in 
maintaining the immune status of the organism. 
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It is now established that Ascorbic acid (AA) performs several important functions in the 
body: -reducing properties of AA do her perfect kosubstrate in monooxygenize hydroxylation 
reactions in the biosynthesis of collagen (hydroxylation of prolin and lysine residues), as well as in the 
reactions of hydroxylation, leading to education noradrenalin, serotonin, carnitin in animal brain. -as 
an oxidant, participates in the protection of both cytozolic and membrane component cells from 
oxidative damage by neutralizing the damaging action of peroxide radicals [1-4]. 
The main role of AA in metabolism is that it is the best (but not the only) factor, it is necessary 
to maintain iron-and copper-containing proteins in restored condition, in which they are most 
functionally active [5]. Human leukocytes can accumulate in the cytozolic to AA concentrations, 
which in 60-80 times higher than plasma concentrations [6.7] 
However, despite the large amount of researches is still functional role of Leukocyte cells type 
AA remains unknown. Although experimentally established fact, that the content of AA in leukocytes 
high, could lead to the assumption that AA has played a major role in their physiological function. 
Materials and methods. Human leukocytes obtained from peripheral blood of adult donors 
fax during natural sedimentation of blood at room temperature. During nearly 4 hours every 30 min 
collected from the cylinder with blood leukocyte layer formed on the surface of the section of plasma 
and erythrocyte settling layer using a plastic Pasteur pipettes. The collected cells are washed twice 
0.9% NaCl solution with the addition of 2% of cattle serum platelet removed by centrifugation at 200 
g for 5 min [8]. 
Then the cells were resuspended concentration to 2.7x10. Of the washed sediments of 
leukocytes, smears were made, fixed, stained and the cellular composition was determined. The 
resulting suspension contained approximately 25% lymphocytes and 75% granulocytes (neutrophils).  
Were prepared two kinds of suspensions:  
- leucocytes with the addition of Ascorbic acid (12 mm) in the tris-buffer (20 mm),  
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- leukocytes, with the addition of tris-buffer (20 mm) without AC. The leukocyte suspensions 
were purged with argon for 5-7 min and incubated them in identical conditions at room temperature. 
At certain intervals were taken samples in teflon tubes with an internal diameter of 3 mm and a length 
of 30 mm and fast freeze them at the temperature of liquid nitrogen. Then the frozen solutions were 
pushed out of tube in liquid nitrogen and samples were obtained in the form of columns with a 
diameter of 3 mm and a length of 30 mm. 
Used «Sigma» company AA. Concentration of AA in cell suspension was 15 mm. The cell 
suspensions were purged with argon for 5-7 min and incubated them under identical conditions at 
room temperature. At certain intervals samples were and quickly frozen them at a temperature of 
liquid nitrogen. 
Registration of ESR spectra. The EPR spectra were measured with X-band X-band radio 
spectrometers ESR 300 from firm equipped with standard programs and ER-220D ("Bruker", 
Germany). The number of produced nitric oxide systems determined by the method of double 
integration of signals nitrozyl complexes hem-NO ESR signal and a reference. The standart was the 
solution in the water nitroxide radicals 4-(N,N-dimethyl-decilamin) - 2,2,6, and 6-tetramethyl-
piperidine-N-oxide in concentration-10-5.  
Results and discussion. Leukocytes and human blood. Suspensions were investigated human 
leukocytes in their incubation in the presence of Ascorbic acid and without it.  ESR spectra are shown 
samples of human leukocytes incubated for for 19 hours at room temperature (~ 18-20) in the presence 
of the AA (fig. 1.1) and without the addition of AA (fig. 1.2). The ESR spectra of leukocytes 
incubated for with AA, recorded EPR signal resulting from the nitrozilnymi complexes gem-NO with 
triplets splitting an = 17 gausses at g = 2.01 [9, 10, 19, 22]. Hemoglobin (≈ 10-5 M) has been preadded 
to the incubation medium as a trap for NO. 
AA and the absence of these complexes in suspensions incubated for without AA indicates 
that under the influence of AA human leukocytes also produce nitric oxide. 
Quantitative assessment showed that in these conditions, under the influence of AA in 
leukocytes produced ~ 6 x-8 x 107 NO molecules per cell. It is known that NO synthesis by cells from 
L-arginine is carried out by special enzymes - NO- nitroxide synthases (NOS). To date, there are three 
types of NOS: endothelial nitroxide synthases (eNOS), neurological nitroxide synthases (nNOS) and 
inducible nitrite oxidase (iNOS). Inducible nitrite oxidase (iNOS) in macrophages activated a number 
of cytokines (such as interferon-γ, interleukins, etc.) and endotoxins [11-19]. AA also likely involved, 
directly or indirectly, it is in induction of iNOS in leukocytes. 
In Figure 1. 2. And ESR spectra are human blood pecimens, incubated for for 6:00 pm in the 
presence of AA (fig. 2.1) and without it (fig. 2.2). 
In the spectrum of blood with the AA also registered nitrozyl complexes of hem proteins by 
ESR signal-NO, indicating the formation of nitric oxide in the blood. The ESR spectra of blood 
samples incubated without adding of AA, is registered in the monitored range only ESR signal plasma 
protein ceruloplasmin g-factor 2.05 (fig. 2.2). 
 
Fig. 1. ESR Spectra of samples of human leukocyte after 19 hours incubation at room temperature:  
1- of ascorbic in the presence of a concentrations 12 mm AA; 2- without added of AA.  
Conditions of registration: Power Over the treble 20 mw, amplitude of modulation of magnetic field in 
5 gausses, temperature 77 K, spectra of 1 and 2 recorded at the same enhancement. 
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NO education in whole blood under the action of AA is also likely responsible, mainly 
leukocytes, so in erythrocytes, as we know, there are no production system NO (see figure. 2. B). 
Perhaps a minor contribution to the formation of NO in the blood could contribute and platelets. 
Thus, the obtained data showed that AA is directly involved in the reaction, that triggers the 
formation of NO cells.  Producing NO leukocytes may also participate in the implementation of 
immune control in blood (and the body), causing the death of pathogenic bacteria and tumor cells. 
That AA is able to support the body's immune system, is known for many years [1-5, 20.21]. But, the 
mechanism of action of AA while remained unclear. We believe that the induction of nitric oxide in 
leukocytes can be one of the main functions of AA in the body. 
The mechanism of action of AA to the formation of nitric oxide in cells so far is unclear. But 
you can suggest two possible variants of its participation in the famous nitric oxide pathway involving 
NO-synthase from L-arginine. Firstly, the AA can play the same role as that of tetrahydrobiopterin 




Fig. 2. EPR Spectra of samples of human blood (a) and (b) erythrocytes incubated for 24 hours at 
room temperature: 1- the presence of a concentration of 12 mm AA; 2-without the addition of AA. 
Conditions of registration are the same as in Fig. 1. 1. 
Secondly, AA may participate in producing substrates NO-synthase, NADPH and in particular 
BH4. The second assumption is based on the available data in the literature about increasing the 
content of NADPH under the influence of the AA and the necessary participation in maintaining BH4 
in restored condition. AA is needed to prevent irreversible oxidation BH4 in digidrobiopterin [22]. 
Conclusions. The research shows that Ascorbic acid is involved in the formation of nitrogen 
oxide in leukocytes of humans and animals. It is expected that is the participation of AA in the 
formation of nitric oxide in immunocompetent cells of humans and animals. Suggests, an important 
role of maintaining the immune status of the organism.  
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